Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vick

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Neurosurgery|March 1, 1986
Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastomaH S Friedman, M S Mahaley, S C Schold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastomaH S Friedman, S C Schold, M S Mahaley, et al.
Applied Optics|November 10, 2010
Binary adaptive optics: atmospheric wave-front correction with a half-wave phase shifterG D Love, N Andrews, P Birch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasmsS C Schold, M S Mahaley, N A Vick, et al.
Microbiology Spectrum|June 21, 2023
Absence of Staphylococcus aureus in Wild Populations of Fish Supports a Spillover HypothesisMarta Matuszewska, Alicja Dabrowska, Gemma G R Murray, et al.
Journal of Medicinal Chemistry|June 14, 2023
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous SolubilityHeeren M Gordhan, Steven T Miller, Daphne C Clancy, et al.
British Journal of Cancer|August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseW K Yung, R E Albright, J Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity TrialTerry A Day, Keisuke Shirai, Paul E O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial resultsD D Bigner, M T Brown, A H Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial resultsM T Brown, R E Coleman, A H Friedman, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Neurosurgery|March 1, 1986
Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastomaH S Friedman, M S Mahaley, S C Schold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastomaH S Friedman, S C Schold, M S Mahaley, et al.
Applied Optics|November 10, 2010
Binary adaptive optics: atmospheric wave-front correction with a half-wave phase shifterG D Love, N Andrews, P Birch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasmsS C Schold, M S Mahaley, N A Vick, et al.
Microbiology Spectrum|June 21, 2023
Absence of Staphylococcus aureus in Wild Populations of Fish Supports a Spillover HypothesisMarta Matuszewska, Alicja Dabrowska, Gemma G R Murray, et al.
Journal of Medicinal Chemistry|June 14, 2023
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous SolubilityHeeren M Gordhan, Steven T Miller, Daphne C Clancy, et al.
British Journal of Cancer|August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseW K Yung, R E Albright, J Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity TrialTerry A Day, Keisuke Shirai, Paul E O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial resultsD D Bigner, M T Brown, A H Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial resultsM T Brown, R E Coleman, A H Friedman, et al.
Pageof 11